Evidence map›Paper›PMID 33983380›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2021

Genomic and Hormonal Biomarkers of Phthalate-Induced Male Rat Reproductive Developmental Toxicity Part II: A Targeted RT-qPCR Array Approach That Defines a Unique Adverse Outcome Pathway.

Leon Earl Gray, Christy S Lambright, Justin M Conley, Nicola Evans, Johnathan R Furr, Bethany R Hannas, Vickie S Wilson, Hunter Sampson, Paul M D Foster

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Phthalates toxicityHeliyon · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Effects of PFAS on human liver transporters: implications for health outcomes.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Leon Earl GrayReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Christy S LambrightReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Justin M ConleyReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Nicola EvansReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Johnathan R FurrInotiv, Gaithersburg, Maryland 20878, USA.
Bethany R HannasCorteva, Agriscience, Haskell R&D Center, Newark, Delaware 19711, USA.
Vickie S WilsonReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Hunter SampsonReproductive and Developmental Toxicology Branch, PHITD, CPHEA, ORD, US Environmental Protection Agency, North Carolina 27711, USA.
Paul M D FosterFuquay Varina.
Environmental Protection Agency · USCorteva (United States) · US

Funding

Intramural EPA EPA999999National Institute of Environmental HealthU.S. Environmental Protection Agency RW-75-92285501-1
6 · The paper itself

Abstract

Previously, we demonstrated that exposure to some diortho-phthalate esters during sexual differentiation disrupts male reproductive development by reducing fetal rat testis testosterone production (T Prod) and gene expression in a dose-related manner. The objectives of the current project were to expand the number of test compounds that might reduce fetal T Prod, including phthalates, phthalate alternatives, pesticides, and drugs, and to compare reductions in T Prod with altered testis mRNA expression. We found that PEs that disrupt T Prod also reduced expression of a unique "cluster" of mRNAs for about 35 genes related to sterol transport, testosterone and insulin-like hormone 3 hormone syntheses, and lipoprotein signaling and cholesterol synthesis. However, phthalates had little or no effect on mRNA expression of genes in peroxisome proliferator-activated receptor (PPAR) pathways in the fetal liver, whereas the 3 PPAR agonists induced the expression of mRNA for multiple fetal liver PPAR pathway genes without reducing testis T Prod. In summary, phthalates that disrupt T Prod act via a novel adverse outcome pathway including down regulation of mRNA for genes involved in fetal endocrine function and cholesterol synthesis and metabolism. This profile was not displayed by PEs that did not reduce T Prod, PPAR agonists or the other chemicals. Reductions in fetal testis gene expression and T Prod in utero can be used to establish relative potency factors that can be used quantitatively to predict the doses of individual PEs and mixtures of phthalates that produce adverse reproductive tract effects in male offspring.

Indexed as

Adverse Outcome PathwaysPhthalic AcidsAnimalsBiomarkersDose-Response Relationship, DrugGenomicsMaleRatsRats, Sprague-DawleyTestisTestosteroneBiomarkersphthalic acidPhthalic AcidsTestosteroneAOPcholesterol metabolismfetal testis gene expressionin utero phthalatePPAR pathwaytestosterone production

Identifiers

PMID33983380
PMCPMC9139873
OpenAlexW3160422226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.